Hope for the best, expect the worst? The interaction between side effect expectations and treatment outcomes of chemotherapy as part of a psychooncological panel study

• Conditions: C00-C97; Malignant neoplasms

• Registration Number: DRKS00028791
• Lead Sponsor: niversitätsklinik HeidelbergAbteilung für Allgemeine Innere Medizin & Psychosomatik

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-04-19
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Tumor patients undergoing outpatient treatment at the NCT Heidelberg; age of majority (= 18 years); sufficient German language skills; ability to give consent and availability of a written declaration of consent.

Exclusion Criteria

Severe cognitive, language, and/or physical impairment; severe psychiatric illness (e.g., addiction, schizophrenia).

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Generic Rating Scale for previous Treatment Experiences, Treatment Expectations and Treatment Effects (GEEE); Herth Hope Index (HHI-D); sef-efficacy (Cancer Behavior Inventory (CBI-BD)); quality of life (Short-Form-Health Survey (SF-12))<br><br>Relevant measurement points: Baseline (treatment initiation), Follow-up1 (after 2 weeks), Follow-up2 (after 8 weeks).

Secondary Outcome Measures

Name	Time	Method
Depression and anxiety (Patient Health Questionnaire-4 (PHQ-4)); adherence (single item)<br><br>Relevant measurement points: Baseline (treatment initiation), Follow-up1 (after 2 weeks), Follow-up2 (after 8 weeks).